Morning Briefing
Summaries of health policy coverage from major news organizations
New York Times Examines Questions Left Unanswered By Microbicide Trial
The New York Times examines a set of questions raised by news out of the International AIDS Conference-AIDS 2010 last week that a microbicide gel containing the antiretroviral (ARV) tenofovir used by women before and after sex helped reduce their risk of HIV infection by 39 percent.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
